The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2,2-Dimethyl-6-oxo-1,2-dihydro-6H-3,11-dioxa-cyclopenta[a]anthracen-10-yl)-acetic acid methyl ester ID: ALA343631
PubChem CID: 11724677
Max Phase: Preclinical
Molecular Formula: C20H18O5
Molecular Weight: 338.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)Cc1cccc2c(=O)c3ccc4c(c3oc12)CC(C)(C)O4
Standard InChI: InChI=1S/C20H18O5/c1-20(2)10-14-15(25-20)8-7-13-17(22)12-6-4-5-11(9-16(21)23-3)18(12)24-19(13)14/h4-8H,9-10H2,1-3H3
Standard InChI Key: JZAXKHJINAJILV-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
10.8917 -1.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8917 -0.5125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6042 -1.7417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.6042 -0.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1875 -1.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3167 -1.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3167 -0.5125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4792 -1.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8667 -1.8792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0292 -1.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2042 -2.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1917 -0.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0167 -2.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7417 -2.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0292 -2.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6042 0.7333 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4750 -0.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4542 -2.5667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0292 -0.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7417 -3.8042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.7417 -1.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7417 -0.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3792 -2.6250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4167 -3.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4542 -4.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 2 1 0
5 1 1 0
6 3 1 0
7 6 2 0
8 5 2 0
9 8 1 0
10 6 1 0
11 13 1 0
12 2 1 0
13 5 1 0
14 15 1 0
15 10 1 0
16 4 2 0
17 8 1 0
18 14 2 0
19 7 1 0
20 14 1 0
21 10 2 0
22 21 1 0
23 11 1 0
24 11 1 0
25 20 1 0
11 9 1 0
17 12 2 0
4 7 1 0
19 22 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 338.36Molecular Weight (Monoisotopic): 338.1154AlogP: 3.38#Rotatable Bonds: 2Polar Surface Area: 65.74Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.32CX LogD: 3.32Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.53Np Likeness Score: 0.65
References 1. Gobbi S, Rampa A, Bisi A, Belluti F, Valenti P, Caputo A, Zampiron A, Carrara M.. (2002) Synthesis and antitumor activity of new derivatives of xanthen-9-one-4-acetic acid., 45 (22): [PMID:12383019 ] [10.1021/jm020929p ]